Anhua Lei
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
CAR-Macrophage Therapy Alleviates Myocardial Ischemia-Reperfusion Injury.
Journal: Circulation research
Published: October 28, 2024
Author Correction: A second-generation M1-polarized CAR macrophage with antitumor efficacy.
Journal: Nature immunology
Published: December 18, 2023
A second-generation M1-polarized CAR macrophage with antitumor efficacy.
Journal: Nature immunology
Published: July 14, 2023
Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors.
Journal: Nature communications
Published: March 15, 2023
Dynamic nucleolar phase separation influenced by non-canonical function of LIN28A instructs pluripotent stem cell fate decisions.
Journal: Nature communications
Published: February 23, 2023
Induced CAR-Macrophages as a Novel Therapeutic Cell Type for Cancer Immune Cell Therapies.
Journal: Cells
Published: February 18, 2022
CAR-macrophage: An extensive immune enhancer to fight cancer.
Journal: EBioMedicine
Published: November 30, 2021
LIN28 coordinately promotes nucleolar/ribosomal functions and represses the 2C-like transcriptional program in pluripotent stem cells.
Journal: Protein & cell
Published: May 22, 2021
Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy.
Journal: Kidney diseases (Basel, Switzerland)
Published: January 09, 2021
Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions.
Journal: Journal of hematology & oncology
Published: October 20, 2020
Strategies for Genetically Engineering Hypoimmunogenic Universal Pluripotent Stem Cells.
Journal: iScience
Published: January 06, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026